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ABSTRACT 
Objective: 
To review the histopathological diagnoses of palatine tonsil diseases and to compare the 
incidence of malignancy in HIV infected and HIV uninfected patients. 
Methods: 
This study is a retrospective record review over the period 1 July 2005 to 30 June 2015. The 
patients were recruited from the Otorhinolaryngology departments at the Chris Hani 
Baragwanath Academic Hospital, Charlotte Maxeke Johannesburg Academic Hospital and 
Helen Joseph Hospital. Records were collected from the National Health Care Laboratory 
database of patients above 18 years of age. 
Results: 
The histology results of 319 patients were obtained. Reactive lymphoid hyperplasia was 
present in the vast majority (77.3%). Fourteen patients had underlying malignancies. 
There were 86 patients who were HIV infected and 74 were HIV uninfected. The rest of the 
patients’ HIV status was not known. Eight malignancies (9.3%) were discovered in the HIV 
infected patients and 6 malignancies (8.1%) were discovered in the HIV uninfected patients. 
There was no statistically significant difference in the incidence of malignancies between the 
HIV infected and uninfected groups. 
Conclusion: 
The majority of patients undergoing tonsillectomy had an underlying benign condition. 
HIV status does not appear to be a risk factor for tonsil malignancies other than Kaposi’s 
sarcoma. 
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INTRODUCTION 
In resource rich centres, histopathology assessments are performed routinely on tonsillectomy 
patients.1 This routine histopathology may reveal unexpected malignant lesions. The 
incidence of unexpected malignant lesions is extremely rare (0.015%)1 but early diagnosis in 
these instances could lead to timely treatment and an improved prognosis. The merits of 
routine tonsillar histopathology in poorly resourced centres have been questioned.2 The staff 
at the Department of Otorhinolaryngology at the University of the Witwatersrand (WITS 
University) request histopathology for suspicious lesions based on the attending doctor’s 
evaluation. 
It has been documented that Human Immunodeficiency Virus (HIV) infection increases the 
risk of malignant lesions.1, 3 There is limited published data on the specific risks of malignant 
tonsillar lesions in Johannesburg. This study aims to assess whether there is a benefit to 
performing routine histopathology on tonsillar specimens in HIV infected and HIV 
uninfected patients. 
We will review the data of tonsillar specimens sent for histopathology from the three 
hospitals affiliated to WITS University namely Charlotte Maxeke Johannesburg Academic 
Hospital (CMJAH), Baragwaneth Academic Hospital (CHBAH) and Helen Joseph Hospital 
(HJH). 
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1.1 Background 
Tonsillectomies are common surgical procedures performed by Otorhinolaryngologists.1 The 
majority of these are routine procedures.  
The indications include: 
• Hypertrophy secondary to inflammatory conditions  
o Allergies 
o Infections 
o Chemical irritations related to post-nasal drip  
o Reflux disease 
• Obstructive Sleep Apnoea 
• Snoring4 
 
Adult tonsillectomies may have a more significant aspect to it. Most are performed due to 
recurrent acute inflammatory disease but some may be due to more serious diseases 
including: 
• Chronic granulomatous diseases 
• Neoplasms 
o Benign 
o Malignant 
 Squamous Cell Carcinoma (SCC) 
The incidence of SCC has increased in the recent past. This may be 
attributed to the increase in infection with Human Papilloma Virus 
(HPV).5 
Factors associated with SCC include4 
• Alcohol consumption 
• Smoking 
• Increasing age 
 Lymphoma (more common in children) 1-3 
 4 
 
Beaty et al in 1998 identified certain features which were statistically significant in patients 
with tonsillar malignancy 
• High risk factors for malignancy 
o History of cancer 
o Tonsillar asymmetry 
o Tonsil firmness 
o Visible lesions 
o Concomitant neck adenopathy 
o Unexpected weight loss 
o Constitutional symptoms (fatigue; night sweats; fever; anorexia)6 
Recent evidence suggests that immunodeficiency should be considered an additional risk 
factor.7 
In resource rich centres, litigation and patient demand drive requests for routine 
histopathology. The rationale behind routine histopathlogy has been questioned especially in 
poor areas where costs are a driving force.2 
The initial recommendation for the performance of routine histopathological examination of 
tonsillar specimens came in 1939 by Starry who in a small series found 2 malignancies.8 This 
practice was only questioned in 1964 by Weibel.8 He examined 3627 tonsillar specimens and 
did not detect malignancy in any of them. He suggested that routine histological analysis 
should only be performed in patients >40 years.8 In recent times numerous studies have also 
brought these practices into question.1,2,8,15,16 
A recent systematic review by Rokkjaer et al (12 studies including 6434 patients) concluded 
that there is inadequate proof for routine histological examinations from patients who do not 
exhibit high risk features.8 
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Two studies from Africa including a paediatric study from South Africa were included in this 
review.1,9 Adoga et al evaluated the histology of 61 tonsillectomy patients (adults and 
children) in Nigeria. They concluded that histological examination of tonsillar specimens was 
indicated in the presence of the risk factors listed above and should not be performed 
routinely.9 
Van Lierop and Prescott concluded from their analysis of 344 specimens that routine 
pathological examination of tonsillar specimens is not indicated in South African children. 
They suggested further criteria to be considered when requesting histopathology studies of 
tonsillar specimens: 
• Positive tuberculosis contact at home 
• HIV infection 
• Rapid tonsillar enlargement1 
 
In view of the limited data in our setting, especially in the adult population where the 
prevalence of HIV infection is high (18% in the adult population) 10, we set out to determine 
whether routine tonsillar histological studies were indicated, especially in HIV infected 
patients.  
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1.2 Gross Anatomy 
The palatine tonsils, pharyngeal tonsils and lingual tonsils are collectively known as 
Waldeyer's ring. See Figure 1.1 below. This lymphoid tissue is found at the entrance of the 
upper aero-digestive tract, being the first primary lymphoid tissue to be exposed to aero-
digestive tract antigens resulting in an immune response. The palatine tonsils are paired oval 
masses located on the lateral walls of the oropharynx.11 They are bounded by the anterior 
tonsillar pillars with its underlying palatoglossal muscle anteriorly and the posterior tonsillar 
pillars with its underlying palatopharyngeus and superior constrictor muscles posteriorly and 
laterally.4, 11 
The blood supply to the tonsils is from the branches of the internal maxillary artery, 
ascending pharyngeal artery, facial artery and lingual artery.11 Venous blood drainage is 
through a peritonsillar plexus. The plexus drains into the lingual and pharyngeal veins. This 
then drains into the internal jugular vein.4, 11 
The sensory innervation is from the glossopharyngeal nerve (special sensory and general 
sensory) and some branches of the lesser palatine nerve (general sensory) via the 
sphenopalatine ganglion.4, 11 
The palatine tonsils do not possess afferent lymphatics. However, efferent lymphatics drain 
directly to the jugulo-digastric lymph nodes and to the upper deep cervical chain of lymph 
nodes of the anterior triangle of the neck.4, 11 
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Fig 1.1Basic illustration of the Waldeyers ring12 
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1.3 The Microanatomy / Histology Of Normal Tonsillar Tissue 
The palatine tonsil consists of lymphoid tissue and a connective tissue frame-work.11 See 
Figure 1.2 below. The surface of the tonsil is covered with non-keratinizing stratified 
squamous epithelium. Epithelial lined tonsillar crypts penetrate nearly the entire tissue. This 
lining epithelium with its stroma are specialised in antigen processing. The crypts serve to 
increase surface area.4, 11 
 
 
Figure 1.2 Microanatomy of palatine tonsils13 
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1.4 Function Of The Palatine Tonsils 
They play an important role in surveillance and response to infection in the upper aero 
digestive tract. They are located in a prime position to act as secondary lymphoid tissue to 
foreign organisms introduced to the oral cavity. The antigen processing is initiated in the 
crypt epithelium and it then travels to the lymphoid follicles of the palatine tonsils, producing 
mature B and T lymphocytes.4,11 
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LITERATURE REVIEW 
2.1. Incidence Of Malignant Lesions In Tonsillar Tissue 
 
Table 2.1: Incidence of Non-Benign Tonsillar Lesions 
Authors No. of 
Patients 
Age 
Group 
Malignant lesions (%) 
Rokkjaeret al 
(2014)8 
72,322 
 
6434 
All ages 
 
Adults 
0.02 (unsuspected malignancy) 
 
0.05 (unsuspected malignancy) 
Hajiioannou et 
al (2014)2 
823 All ages 0 (unsuspected malignancy) 
Randall et al 
(2007)15 
54,901 All ages 0.011 (unsuspected malignancy) 
0,09 (suspected and unsuspected) 
 
 
Courville et al 
(2011)11 
1997 Adults 0 (unsuspected malignancy) 
4 (suspected and unsuspected) 
* 30% of patients who had a suspicious lesion had a malignancy 
 
 
Suspected Malignancy refers to the presence of the following risk factors: 
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• History of cancer 
• Tonsillar asymmetry 
• Tonsil firmness  
• Visible lesions 
• Concomitant neck adenopathy  
• Unexpected weight loss  
• Constitutional symptoms8 
The world-wide incidence of tonsillar tumours is rare, accounting for only 0.05% of the 
tonsillectomy population.5, 14. The most common malignancies of the palatine tonsil in adults 
are squamous cell carcinoma (SCC) and lymphoma5, 8, 14 
 
Rokkjaer et al (2014) performed a systematic literature review to determine the prevalence of 
unsuspected tonsillar malignancy. Their review included 72,322 patients of all ages and 
showed that only 0.02% of the patients had unsuspected malignancy. From extrapolation of 
the data only 0.05% of adults (above 18 years) who had a tonsillectomy, were found to have a 
non-benign lesion. They surmised that the high costs of testing all patients versus the 
opportunity of prolonging life by discovering an early lesion still needed further study.8 
 
In 2014 Hajiioannou et al conducted a retrospective review of 823 tonsillectomies. They 
included patients of all age ranges and found no unsuspected malignancies. Thirty percent of 
the patients reviewed were above 18 years of age. They concluded that histopathological 
examination of tonsillectomy specimens is only indicated in patients with previously 
described clinical criteria that were suggestive of underlying malignancy.2 
 
Randall et al (2007) performed a systemic review of 20 studies of tonsillectomy histology. 
Some of the studies in the review included adenoidectomy histology. There were 54,901 
patients that had undergone tonsillectomies (ages ranged from 2 to 72years). Only 0.01% of 
 13 
 
the patients had an unsuspected malignant lesion. None of the patients with an unsuspected 
malignancy were adult. There were 2138 adult patients, 25 (1.2%) of whom had a 
malignancy. Crucially all these adult patients had at least one risk factor for a suspected 
malignancy.15 
 
Courville et al (2011) performed a retrospective review of 1997 adult tonsillectomy histology 
specimens performed over a 45 month period. In their study, 75 patients (3.7%) had 
squamous cell carcinoma; 11 (0.5%) had a lymphoproliferative disorder and 1 patient 
(0.05%) had a muco-epidermoid lesion. These were all suspected malignancies as the patient 
had identifiable risk factor/s. No unsuspected malignancy was found. Malignant lesions were 
detected in 30% of patients with “suspected malignancy”. The authors concluded that the 
indication for sending a specimen for histology in an unsuspected case should be institution 
based as no study on the consequences of missing an undetected tonsil malignancy has been 
done16. 
 
Few studies have documented the effect of HIV infection on tonsillar histology. One Nigerian 
study by Adoga, et al (2011) reviewed 61 patients. The cohort comprised 35 children and 26 
adults. They did not comment on the number of patients with HIV infection; although they 
did detect lymphoma in an adult patient with HIV. They concluded that a request for 
histopathology on tonsillectomy specimens should be based on the presence of established 
risk factors with consideration of the cost to patients and to spare histopathological 
resources.9 
 
 
A South African Study, by Lierop et al (2009), evaluated the impact of HIV on the incidence 
of adeno-tonsillar lesions in the paediatric population. Of the 172 patients evaluated in their 
study, 50% were HIV positive. They detected only one case of lymphoma. That patient was 
 14 
 
HIV negative. They concluded that, given the high cost of pathological examinations, routine 
pathology would not be cost effective, even with consideration of medico-legal prosecution.1 
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2.2 Human Papilloma Virus And Malignant Tonsillar Lesions 
The Human Papilloma Virus (HPV) is a small non enveloped DNA virus. These viruses are 
found in the basal layer of epithelial cells present, where they replicate via a break in the skin 
or mucosa.17 An increase in the incidence of oropharyngeal squamous cell carcinoma has 
been documented worldwide; this is associated with the new recognition of human papilloma 
virus as a cause of SCC 5, 17. In the United States of America (USA) the incidence of 
oropharyngeal cancer has increased from 3.5 to 4.5 per hundred thousand between 2000 and 
2010 indicating that the rate of tonsillar tumours increased 2-3% on a yearly basis.5 This 
pattern follows a recent change in sexual behaviours.17,18 Patients with HPV head and neck 
malignancy are usually younger and have an equal distribution between men and women, 
these patients do not have a history of smoking or alcohol intake in contrast to smoking 
related cancers.17,18 
 
HPV is most commonly associated with the oropharynx in head and neck lesions possibly 
due the similarity of the mucosa to that of the uterine cervix, specifically the crypts of the 
tonsils.17 HPV is transmitted peri-natally during vaginal births, sexually and via direct 
contact. HPV 16 and 18 are considered high risk subtypes implicated in malignancy. HPV 16 
has been found in 90% of HPV positive cases of malignant head and neck tumours.17, 18 
 
The mechanism of HPV carcinogenesis is via the encoding of HPV E6 and E7 oncogenes 
which bind to and inactivate tumour suppressors’ p53 and retinoblastoma tumour suppressor 
protein(Rb) respectively. This results in uncontrolled cell growth.17, 18 
 
It has been demonstrated that patients with oropharyngeal squamous cell carcinoma 
secondary to HPV have a better prognosis than patients in whom the malignancy is presumed 
to be secondary to smoking. Currently quadravalent and bivalent HPV vaccines appear to be 
 16 
 
reducing the occurrence of cervical malignancy, this effect may extend into oropharyngeal 
cancers but definitive trials are pending.17, 18 
2.3 HIV and the Palatine Tonsil 
The palatine tonsils play an important role in immunologic surveillance and resistance to 
infection in the upper aero digestive tract.See Figure 2.1 below. Palatine tonsils taken from 
individuals infected with HIV-1 have shown infected lymphocytes localized to the surface of 
the tonsillar crypt epithelium. Thus HIV may replicate rapidly at this site due to the numerous 
T-cells and dendritic cellspresent. HIV is rarely transferred through the oral cavity and 
oropharynx as long as the mucosa is intact as demonstrated by a laboratory experiment 
whereby minimal transfer of HIV was found after human tonsillar tissue was bathed in HIV 
semen with an intact mucosa.19 
 
The effects of HIV on the palatine tonsil are as follows: 
 
• Acute phase of HIV infection 
• The secondary lymphoid organs show follicular hyperplasia and proliferation 
of vascular stroma. 
• The germinal centres of these organs are important reservoirs of free virus. 
• Disease progression 
• Germinal centres lyse and involute. 
• Cluster of Differentiation (CD4) T cells deplete. 
• Increased collagen deposition in the palatine tonsils. 
• Greater depletion of CD4+ T cells.20 
 17 
 
 
Fig 2.1 Infection of tonsil by HIV21 
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2.4 HIV And Benign Oral Lesions 
 
The following oral lesions are more common in individuals with underlying HIV infection: 
• Tuberculosis (TB) 
• Syphillis 
• Candidiasis 
• Hairy leukoplakia 
• Aphthous ulcers  
• Herpes simplex viral infections3 
 
HIV infection has been shown to result in a 30 times greater risk of developing tuberculosis.1 
TB of the tonsils however is a rare entity, with only a few cases having been reported. It is 
thought that saliva has a protective effect, making upper respiratory tract infections rare.23 TB 
involving the tonsil is very rare because of pasteurization which destroys the bovine strain of 
tuberculosis contained in cow’s milk. The tonsils are exposed in the oral cavity but due to the 
antiseptic nature of saliva, the presence of commensal organisms and the stratified squamous 
epithelium in the oral cavity; infection of the tonsil rarely occurs. Patients can present with 
caseating material from the tonsil mimicking a malignancy.22, 23 
 
Syphilis is also a rare presentation of tonsillitis occurring with ulcers involving the tonsils. 
Patients may not describe genital symptoms and the diagnosis is occasionally discovered un-
expectantly via biopsy.24 
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Actinomycosis is a subacute-to-chronic bacterial infection caused by filamentous, anaerobic-
to-microaerophilic bacteria in the oral cavity.2 They are commensals which can cause 
recurrent tonsillitis. Actinomycosis can be exacerbated in immune compromised patients and 
those with poor dental hygiene.25 It is important to diagnose this organism as symptomatic 
patients may require long term antibiotics.25, 26 
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2.5 HIV And Malignant Lesions 
HIV infection is associated with an increased risk of a range of malignancies: 
• Acquired Immunodeficiency Syndrome (AIDS)-defining (virus related) 
o Kaposi sarcoma (KS) 
o Non-Hodgkins lymphoma (NHL) 
o Cervical cancer 
• Non–AIDS defining carcinomas (NADC) 
o Lung 
o Liver 
o Anal  
o Tonsillar3 
 
In the case of tonsillar malignancies, co-infection with HPV was thought to be responsible for 
the increase but HIV in itself may play a role.3 
 
KS is a frequently reported mesenchymal neoplasm characterized by neoangiogenesis, and 
endothelial-derived, spindle shaped tumour cells in HIV infected people and it is caused by 
Human Herpes Virus 8(HHV8). KS is usually isolated to the skin and oral mucosa although it 
may also occur in the  lungs, the liver, the stomach, the bowel and lymph nodes. It has been 
described in specific mucosal sites including the pharynx, larynx, nasal cavity, oral cavity and 
the palatine tonsil.27 
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Lymphomas are the most common malignancy in HIV-infected individuals. They represent 
more than 50% of AIDS related malignancies. HIV associated lymphomas are usually: 
• High grade 
• Clinically advanced at presentation 
• Associated with extra nodal disease 
Common NHL occurring with HIV are diffuse large B cell lymphoma and Burkitt’s 
lymphoma. Hodgkins lymphoma does occur, but not as commonly as NHL.7 
Mitsuyasu in 2013 reviewed the cancer and HIV matched registries from the USA and 
documented his findings (see graphs below). Significant findings were an increased incidence 
of liver, anal and lung malignancies in HIV infected patients. Hodgkins lymphoma was also 
found in larger numbers in older HIV infected patients.28 
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Figure 2.2 Graph depicting differences of NADC in HIV infected and uninfected                                                                                 
individuals28 
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It has been shown that for NADC the CD4 count does not appear to play a singular role in 
carcinoma development.3, 28  It is thought that co infection with certain viruses resulted in an 
increased incidence of malignancy. The viruses implicated are HPV, EBV (Epstein Barr 
Virus), Hepatitis Band C and HHV 8.28 There is also a growing body of evidence that HIV 
has a direct effect on oncogenes and inactivates tumour suppressor genes; it may even cause 
more susceptibility to the effects of the co-existing viral infections. It has been shown that 
cells involved in the immune system of HIV positive patients have a shortening of the 
telomeres.7 This may indicate that HIV positive patients have a more rapid rate of 
immunologic aging predisposing to malignancy7, 28. 
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MATERIALS & METHODS 
3.1 Hypothesis 
Routine histopathology of tonsillectomy specimens is unwarranted in the absence of 
identified risk factors. 
South Africa has a high prevalence of HIV disease. This could result in an associated increase 
in the number of patients with specific HIV-related pathology of the palatine tonsils 
(specifically malignant lesions) compared to the HIV-uninfected.  
3.2 Aims And Objectives 
 
• To review the histopathological diagnoses of routine palatine tonsil diseases as seen in the 
Department of Otorhinolaryngology at the academic hospitals affiliated to WITS 
University. 
• To compare the histological findings in HIV infected and HIV uninfected patients. 
 
3.3 Study Design 
This study is a retrospective record review.  
• Study period  
A 10-year period from 1 July 2005 to 30June 2015. 
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3.4 Study Location 
The study was conducted in the clinical units of University of the Witwatersrand’s 
Department of Otorhinolaryngology at the following hospitals: 
• CHBAH 
• CMJAH 
• HJH 
3.5 Study Population 
The study population included all patients older than 18 years of age, who had a 
tonsillectomy performed with a histological analysis over the defined study period. 
 
3.5.1   Inclusion criteria 
• All adult patients who had a tonsillectomy performed and for whom 
histopathological results were available on the National Health Laboratory 
Services (NHLS) database. 
• Patients who had been clinically assessed by members of the Department of 
Otorhinolaryngology. 
 
3.5.2 Exclusion criteria 
 
• Inadequate data 
 
3.6 Data Collection 
Patients were identified from the ENT Operating Theatre Register, This information was used 
to obtain histopathology and blood results from the NHLS database. 
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3.7 Data Recorded included (see Appendix B): 
• Hospital registration number 
• Age 
• Date of surgery 
• Histology result 
• HIV results 
• CD4 count 
 
3.8  Data Analysis And Presentation 
• See results chapter 
3.9  Ethics Committee Approval (see Appendix A) 
• Ethics approval was obtained in March 2016.  
 
3.10 Limitations 
 
• Limited number of patients 
• No HPV testing 
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RESULTS 
4.1 Introduction 
The association between HIV status and palatine tonsil cancer status is examined using cross-
tabulation, and the statistical significance of the association will be tested using the chi-
square test of independence. A chi-square test of independence is applied to the values 
obtained. Furthermore, a multinomial regression (logistic regression) is carried out to explain 
the same relationship, using the odds ratio. Success is represented by malignant lesions and 
failure by a benign lesion. A benign tumour is defined as a tumour that does not invade 
adjacent tissue, while a malignant tumour is defined as a tumour that invades and causes 
destruction of surrounding tissues.29 
All the statistical tests were carried out with a 5% significance level. One of the conditions of 
the use of the chi square test is that, expected frequency count for each cell in the contingency 
table, must be at least 5.  
All the analyses were carried out using the Statistical Packages for Social Sciences version 13 
and with the assistance of Matondo Lusembo, a statistician. 
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4.2 Ages Of Patients 
 
Table 4.1: Descriptive statistics of age  
 
 
Count Minimum Maximum Median Mean Standard Deviation 
Age 319 18 77 33 34.98 11.99 
 
The ages of patients in the study range from 18 to 77 years old, with a mean age of 35 years 
and a standard deviation of 12 years as presented above.  
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4.3 Population Distribution Per Hospital 
 
 
Figure 4.1 Distribution of hospital patients from each facility in this study 
The Data collected indicates that 46% of patients in the study are from CHBAH, 42% from 
HJH and only 12% from the CMJAH. 
 
 
 
 
 
147 (46,1%)
38 (11,9%)
134  (42%)
Hospitals
CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL
CHARLOTTE MAXEKE ACADEMIC HOSPITAL
HELEN JOSEPH ACADEMIC HOSPITAL
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4.4 HIV Results 
 
Figure 4.2 Distribution of the HIV results 
 
The results of HIV test are presented in Figure 4.2. Half of the patients did not have HIV test 
results available. The majority (54%) of patients, for whom HIV results were available, had 
underlying HIV infection.  
 
 
 
 
4.5 HIV Results Per Hospital 
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Figure 4.3 Distribution of HIV results per hospital 
 
HJH had the highest percentage (approximately 70%) of HIV positive patients followed by 
CMJAH and CHBAH, with 55% and 41 % respectively.  
 
 
 
 
4.6 Histology Results In All Patients 
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Figure 4.4 Histology Results in all patients 
 
The tonsil histopathology test results of patients reveal that reactive lymphoid hyperplasia 
was the most (77%) common pathology encountered amongst our patients. This was followed 
by actinomycosis infection which was documented in 14% of patients.  
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Figure 4.5: Histology results among the HIV Infected Patients 
 
Figure 4.5 above and Figure 4.6 below indicate the distribution of tonsillar histopathology 
results in HIV infected and uninfected patients respectively. In both groups, reactive 
lymphoid hyperplasia was found in 77% of patients. Actinomycosis was found in 12% of 
patients in the HIV infected group while in the HIV uninfected patients it was observed in 
11%.  
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Figure 4.6 Histology results among the HIV uninfected patients. 
 
 
 
 
4.9 Distribution Of Malignant And Benign Lesions 
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Figure 4.7 Distribution of Malignant and benign lesions 
 
It can be seen that 95.6% of the specimens had benign lesions while in 4.4% the lesions were 
malignant. 
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4.10 Chi Square Test Of Independence 
In this section, the association between malignancy and the HIV results are presented. See 
Table 4.2 below.  
 
Table 4.2 The association between Malignancy and HIV status 
 HIV Results Total 
Positive Negative 
Malignant 8 6 14 
Benign 78 68 146 
Total 86 74 160 
Chi Square Statistic= 0,071; P-value= 0,790 
 
 
Among the 160 patients whose HIV test results are known, 86 (53.8%) are HIV infected and 
74 (46.2%) are HIV uninfected. The majority of patients (both HIV positive and negative) 
had benign pathology of their tonsils. In the HIV infected patients, 8 patients (9.3%) had a 
malignant pathology. Six patients (8.1%) had malignant pathology in the HIV uninfected 
group.  
To test whether the malignant pathology was independent of HIV disease, the chi-square test 
of independence was carried out. In this test, the null hypothesis (H0) was that the malignant 
pathology is independent of HIV disease and the alternative hypothesis (H1) is that they are 
dependent. As the p-value is 0.790 greater than 0.05 (5%), we fail to reject H0, at 5% 
significance level.  
We concluded that there is no statistical evidence at 5% significance level, that the malignant 
pathology is related to HIV.  
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4.11 Logistic Regression 
To predict the likelihood of having malignant tonsillar pathology in the presence of HIV 
infection, logistic regression was carried out. The result of the logistic regression of the 
malignant pathology result based on HIV results and age is presented in Tables 4.3 and 4.4 
below. 
Note that, the Odds ratio values in Table 4.4 are actually the adjusted Odds ratio, which is 
reported when multiple independent variables are used in the model. It indicates the 
contribution of a particular predictor when other predictors are controlled. That is for HIV 
results, the Odds ratio indicates the contribution of HIV infection while controlling or 
adjusting for age.  
 
Table 4.3 Codification of categorical variables in logistic regression 
Dependent variable encoding 
Original value Internal value 
Benign 0 
Malignant 1 
 
Categorical independent variable codings 
  Frequency Codings 
(1) 
 Negative 74 0 
 Positive 86 1 
 
Table 4.3 above shows the coding of categorical variables. The first one is the dependent 
variable i.e. the malignant pathology and the second one is the independent variable i.e the 
HIV result. 
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For the dependent variable: 
• 1 is used as the event occurring (Malignant)  
• 0 as the absence of event (Benign).  
 
For the independent variable (HIV result):  
• 1 is used for the HIV positive category   
• 0 for the category of reference or control group (HIV negative) 
 
Table 4.4 Logistic regression of Malignancy at age and HIV results 
 
Variable Coefficient Wald statistic Significance Odds ratio 
Age -0,05 5,66 0,02 0,95 
HIV-Result 
(Positive) 
0,32 0,30 0,59 1,38 
Constant 4,26 19,73 0,00 71,11 
 
The logistic regression was performed to test the effects of age and HIV infection on the 
presence of malignant lesions. The results indicated that when controlling the effect of age in 
the model, HIV infected patients are 1.380 times more likely to have malignant tonsillar 
pathology than the HIV uninfected patients. The Wald tests showed that only age 
significantly predicted the presence of malignant pathology (p-value= 0.017). HIV did not 
significantly predict the presence of the malignant pathology (p-value = 0.586). This result is 
in accordance with the chi square test in Table 4.2.  
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4.12 Effect Of CD4 Count On Malignant Lesions 
 
Table 4.5 CD4 count  
 
 
 
The CD4 counts encompass a wide range as evidenced by the value of this standard 
deviation.  
 
 
 
 
 
 
 
 
 
 
Count Minimum Maximum Median Mean Standard 
Deviation 
CD4 Count 
(cells/mm3) 
107 6,00 1439,10 369,00 431.17 327.03 
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Table 4.6 Comparison between CD4 count below 200 and malignant lesions 
 
 CD4 Count (cells/mm3) Total 
<=200 >200 
Malignant Lesion 2 5 7 
Benign Lesion 27 73 100 
Total 29 78 107 
Chi Square = 0,008; P-value= 0,928 
 
Patients with a lower CD4 count (below 200 cells/mm3), would be expected to have more 
severe HIV disease and therefore a greater chance of having an HIV associated malignancy. 
In our study, a low CD4 count does not appear to affect the occurrence of malignant lesions. 
(p-value 0.928). 
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Summary of significant results 
• Benign lesions (benign lymphoid hyperplasia) was most common in all patients  
(HIV infected and uninfected) 
• Advancing age was the only predictor of malignancy 
• HIV status did not result in increased overall malignancy 
• Half of the patients undergoing tonsillectomy had HIV results available; and of this 
sub-group approximately 50% had underlying HIV infection 
• No association between CD4 count and occurrence of malignancy 
• All patients with KS had underlying HIV infection 
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Chapter 5 
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DISCUSSION 
5.1 Benign Lesions  
Table 5.1 Comparison of benign histology results  
 
Authors  No. of 
Patients 
Age Group 
(Years) 
Reactive 
lymphoid 
hyperplasia 
(%) 
Reactive 
lymphoid 
hyperplasia 
with 
Actinomycosis 
identified (%) 
Tonsillar 
cyst(%) 
Granuloma 
(%) 
TB 
(%) 
Papilloma 
(%) 
Ikram et al30 200 4-49 99.5      
Younis et al31 339 Above 18 88.7      
Lierop and Prescott1 344 Below 18 93.6 5.8   0,3  
Courville et al11 1093 Adults Just stated as benign, no further detail on benign lesions 
Randel et al15 54,901 All ages Just stated as benign, no further detail on benign lesions 
Dell'Aringa et al32 250 2-34 97 0.8 0.8 0.,4   
Our study 319 18-77 77.3 14.2 0.3 0.3 0 0.6 
 
We reviewed 319 tonsillectomy specimens. The most common finding on histopathology was 
reactive lymphoid hyperplasia which is an inflammatory reaction, mainly due to infection but 
can also be due to chemical irritation or allergies.4 This was present in 245 (77.3%) patients. 
The findings were equivalent in both the HIV infected and HIV uninfected groups. 
Our findings are consistent with previously published studies which found reactive lymphoid 
hyperplasia in the vast majority of patients (see table 5.1 above). Ikram et al reviewed 400 
tonsillectomy specimens. Their patients were aged between 4-49 years. In their cohort 273 
(99%) patients had reactive lymphoid hyperplasia.30 Younis et al31 reviewed the 
histopathology reports of 339 adult tonsillectomy specimens. Reactive lymphoid hyperplasia 
was identified in 299 (88.7%) patients.31 
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There is minimal data available on the histopathology of routine tonsillar specimens in the 
adult HIV infected population. A South African Study, by Lierop et al, reviewed the tonsil 
histology in 344 paediatric patients.1 Reactive lymphoid hyperplasia was present in all the 
patients with HIV infection (4 patients). Our findings suggest that reactive lymphoid 
hyperplasia remains the most common finding in patients undergoing tonsillectomy, 
regardless of HIV status or age. 
Dell'Aringa et al studied 250 patients between the ages of 2 and 34. Of these 245 (95%) had 
lymphoid hyperplasia or inflammation; 2 (0, 8%) had tonsillar cysts and 2 (0,8%) had 
actinomycosis infection. In our study which was of a similar size the population was older. 
There were greater proportions of patients with Actinomycosis 45 (14%); SCC 8 (2.5);KS 7 
(2.2%) and lymphoma 4 (1.3%). In both studies granulomatous disease was present in only 
one patient.32 
Actinomyces are commonly found in the oral cavity where they are commensals. Their role 
in the development of tonsillar disease has not been firmly established.25, 26 In our study 
actinomycosis was equally present in both patients with (11.6%) and without HIV (10.8%). 
The presence of actinomycosis infection in tonsillectomy specimens is well described. 
Rebechi et al evaluated the routine histopathology of 281 patients who underwent 
tonsillectomy, most of whom had recurrent bouts of infection. They found evidence of 
chronic tonsillitis with colonies of actinomyces in 9.6% of their patients.33 In view of our 
findings we concur with Hasan et al who suggested that actinomycosis is likely to have a 
causal association with recurrent tonsillitis and tonsillar hypertrophy.34 
 
South Africa has one of the highest burdens of TB in the world, with an estimated 450 000 
active cases in 2013.35 We however did not detect any evidence of TB in the specimens that 
we reviewed. This is not unexpected as tonsillar involvement in TB infection is rare. 
Ricciardello et al looked at otorhinolaryngology-related TB in 304 patients. Their study was 
conducted in Naples. They found tonsillar involvement in only 2 patients.36 
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5.2 Malignant Lesions 
SCC is the most common malignancy in patients with non-benign tonsillar lesions. It 
accounts for up to 7% of malignancies. Courville et al11 tested 1093 adult patients. Of, these 
75 (7%) had SCC.11 Malignancies were suspected prior to the confirmatory histology in all of 
their patients. Eight of our patients (2.5%) had SCC on pathological evaluation. The HIV 
results were only available for 4 patients; three were uninfected and 1 patient had associated 
HIV infection. Randel et al found 22 patients with SCC (0.04%). They reviewed 54 901 
tonsillectomy specimens. The relatively low overall prevalence in their study is probably due 
to the high number of paediatric tonsillectomy specimens (96%). In their adult population 
SCC was present in 25 patients (1.2%).15 
Lymphomatous lesions are well described in patients with tonsillar malignancy. Their 
occurrence ranges from 0% to 1.74%.1, 11, 15, 30-32 Ikram et al studied 200 patients between the 
ages of 4 to 49. They detected lymphoma in only one patient (0.5%).30 Younis et al evaluated 
the routine histopathology in 2438 specimens. Their cohort was mainly children (2099). In 
the 339 adult specimens they reviewed they detected lymphoma in 6 patients (1.74%). All 
their lymphoma patients had suspicious clinical findings pre-operatively. We had 4 patients 
(1.3%) with lymphoma; one of these patients had concomitant HIV infection. 
In our study advancing age was the only predictor of malignancy. 
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5.3 HIV Testing 
The estimated prevalence rate of HIV is approximately 12.7%. This is about 7.03 million of 
the estimated South African population, with the highest prevalence of 18% in the age group 
15-49years.37 In half of our patients HIV results were unavailable. In the patients in whom the 
HIV status was known; approximately half were infected. These findings suggest that more 
vigorous testing is required for those adults admitted for tonsillectomies and tonsillitis. 
5.4 Malignant Lesions And HIV 
The relationship between tonsillar malignancies and underlying HIV is not well established. 
We found 14 patients with malignancies, of those 8 were HIV infected and 6 were HIV 
uninfected. The results showed no significant correlation between tonsil malignancy and HIV 
infection.  
HIV infection is associated with an increased risk of a range of cancers, including KS, NHL 
and cervical cancer, which are considered virus-related and AIDS-defining diseases. The 
spectrum and incidence of NADC (smoking and virus related) has also been shown to be 
augmented. Franzetti et al found a higher than expected incidence of tonsil carcinoma in their 
review of 5924 HIV infected patients.3 Mitsuyasu reviewed the incidence of both AIDS-
defining and NADC in the USA. He did not find an increased incidence of tonsillar 
malignancies.28 Grulich et al performed a meta-analysis of people with HIV/AIDS (444 172 
patients). They found an increased incidence of oral cavity and pharyngeal tumours. 
Unfortunately they did not specify whether any of their patients had tonsillar malignancies.38 
It has been hypothesised that the malignancies associated with HIV, are due to co-existing 
viral infection such as HPV, EBV, hepatitis B and C and HHV 8.28, 38 
 
In our study KS was detected in 7 patients, all of whom were HIV infected. There is an 
established strong correlation between HIV and KS which has been borne out in the 
literature. 3, 28, 39 and 40 HIV infected individuals in Southern Africa have a higher risk of 
developing KS than their counterparts in Europe.39Prior to the HIV epidemic, the prevalence 
of KS was low in Africa. There has been a marked surge in the number of KS cases.  
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HHV8 is implicated in this resurgence of KS. The mechanism of how HHV8 causes KS is 
not completely understood but it is believed to be instigated by oncoprotein production and 
the inhibition of tumour suppressor genes.40AIDS-related KS is the most aggressive sub-type. 
It usually begins in the head and neck. This may be due to the fact that the oropharynx is the 
main reservoir for HHV8.40 
Our study did not find an association between tonsil malignancies.  
5.5 Relationship Between CD4 Count And Malignancy 
Franzetti et al found a significant association between NADC and low nadir CD4 counts 
(<200cells/mm3). They evaluated 5924 HIV infected patients over a 26 year period. They 
used regression models to compare the cancer risk in their HIV infected patients to age and 
gender-matched individuals. We could not confirm this relationship. We cannot exclude the 
possibility that the retrospective nature of our study, the relatively small number of events 
and the large deviations of CD4 counts would make our results less reliable. 
Advancing age was the only predictor of malignancy in both the HIV infected and uninfected 
sub-groups. 
 
5.6 Cost Vs Benefits 
Hajiioannou et al showed that the cost per patient for routine histology was 50 Euros (R735). 
They suggested that the cost of performing routine tonsillectomy histology was not warranted 
due to the extremely low detection of occult malignancies2. 
The cost of tonsil histology in the public sector is approximately R200-400. This price is 
based on the size of the tonsil.41 Medico-legal costs related to undetected malignancies can be 
exorbitant and consequently there is no standard protocol to decide whether adult specimens 
should be sent for histology.  
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5.7 Conclusion 
The discussion about routine tonsillectomy histology remains controversial even though the 
extensive literature review has shown extremely low levels of malignancy in unsuspicious 
lesions.1, 2 Proponents fear missing malignancies and detractors believe the costs seldom 
justify the benefits.  
Tonsil histology should probably be reserved for patients with clinically suspicious lesions 
independent of HIV status. 
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Appendix B 
Data Sheet  
Hospital 
number 
sex age Date of 
surgery 
HIV 
status 
CD4 
count 
Histology 
results 
      Malignant 
or benign 
lesion 
       
 
Link Form 
Patient number Hospital number 
1 Gt........ 
2 Gp......... 
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